BOLZATI, CRISTINA
BOLZATI, CRISTINA
64Cu-Labelled compounds with dithiocarbamate ligands for theragnostic applications: preliminary in vitro studies
2012 Morellato, Nicolo'; Gandin, Valentina; G., Cicoria; Salvarese, Nicola; Marzano, Cristina; S., Costa; F., Lodi; Bolzati, Cristina
99mTc(N)(DASD)(pnpn)]+ (DASD=1,4-dioxa-8-azaspiro[4,5]decandithiocarba pnpn=bisphosphinoamine) for myocardial imaging
2019 Bolzati, Cristina; Salvarese, Nicola; DE NARDO, Laura; MELENDEZ ALAFORT, Laura; Gandin, Valentina; Carta, Davide; Marzano, Cristina
99mTc(N)-DBODC(5) from cardiology to oncology: preliminary in vitro study
2011 Dolmella, Alessandro; Carta, Davide; Gandin, Valentina; Marzano, Cristina; Salvarese, Nicola; Morellato, Nicolo'; Colabufo, N. A.; Berardi, F.; Perrone, R.; Bolzati, Cristina
99mTc(N)-DBODC(5), a potential probe for SPECT imaging of multidrug resistance: in vitro study
2012 Bolzati, Cristina; Carta, Davide; Gandin, Valentina; Marzano, Cristina; N., Morellato; Salvarese, Nicola; R., Perrone; N. A., Colabufo
99mTc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study
2013 Bolzati, Cristina; Carta, Davide; Gandin, Valentina; Marzano, Cristina; Morellato, Nicolo'; Salvarese, Nicola; M., Cantore; N. A., Colabufo
[99mTc(N)(DASD)(PNPn)]+ Compounds as Myocardial Perfusion Imaging Agents.
2020 Bolzati, C; Melendez-Alafort, L; Carpanese, D; De Nardo, L; Gandin, V; Marzano, C; Salvarese, N
[99mTc(N)(DBODC)(5)]+: sub-cellular distribution and metabolism studies of this new potential myocardial imaging agent
2009 Bolzati, Cristina; M., CAVAZZA CECCATO; F., Refosco; S., Tokunaga; Salvarese, Nicola; Carta, Davide; Dolmella, Alessandro; Casara, Dario; Bandoli, Giuliano
[99mTc(N)PNP]-scaffold for SPECT of multidrug resistance: Early in-vitro study
2014 Bolzati, Cristina; Gandin, Valentina; Morellato, Nicolo'; Salvarese, Nicola; Marzano, Cristina; Carpanese, Debora; MELENDEZ ALAFORT, Laura; Rosato, Antonio
[99mTc][Tc(N)(DASD)(PNPn)]+ (DASD=1,4-dioxa-8-azaspiro[4,5]decandithiocarbamate, PNPn=bisphosphinoamine) for myocardial imaging: synthesis, pharmacological and pharmacokinetic studies
2018 Salvarese, Nicola; Carta, Davide; Marzano, Cristina; Gerardi, Gabriele; Melendez-Alafort, Laura; Bolzati, Cristina
[Re-188(N)(cys similar to)(PNP)](+/0) mixed ligand compounds as models for target specific agents
2010 Bolzati, Cristina; Thieme, S; Agostini, S; Carta, Davide; Salvarese, Nicola; Refosco, F; Bergmann, R; Pietzsch, J; Pietzsch, Hj
A bis(thiosemicarbazone) bifunctional chelating agent for Nitrido-Technetium-99m and Copper-64 based radiopharmaceuticals
2017 Salvarese, N.; Spolaore, B.; Marangoni, S.; Pasin, A.; Galenda, A.; Refosco, F.; Cicoria, G.; Bolzati, C
A bis(thiosemicarbazone) bifunctional chelating agent for nitrido-technetium-99m and copper-64 based radiopharmaceuticals
2018 Salvarese, N.; Spolaore, B.; Marangoni, S.; Pasin, A.; Galenda, A.; Cicoria, G.; Tamburini, S.; Bolzati, C.
Assessment of the best N3− donors in preparation of [M(N)(PNP)]-based (M=99mTc-; 188Re) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG600-DTCZ)
2014 Carta, Davide; Christian, Jentschel; Stefan, Thieme; Salvarese, Nicola; Nicolò, Morellato; Fiorenzo, Refosco; Paolo, Ruzza; Ralf, Bergmann; Hans Jurgen, Pietzsch; Bolzati, Cristina
Biologically relevant Cu2+ complexes with a tridentate phenanthroline analogue: structural properties and DNA damage
2015 Morellato, Nicolo'; Musetti, Caterina; Palumbo, Manlio; Dolmella, Alessandro; Bolzati, Cristina; Sissi, Claudia
Chelating Systems for 99mTc/188Re in the Development of Radiolabeled Peptide Pharmaceuticals
2012 Bolzati, Cristina; Carta, Davide; Salvarese, Nicola; Fiorenzo, Refosco
Comparison of preclinical dosimetric studies of 177Lu-scFvD2B, 177Lu-PSMA-617 and 177Lu-iPSMA.
2022 Meléndez-Alafort, Laura; Ferro-Flores, Guillermina; Ocampo-Garcia, Blanca; Santos-Cuevas, Clara; Carpanese, Debora; Fracasso, Giulio; Bolzati, Cristina; Rosato, Antonio; DE NARDO, Laura
Conjugation and characterization of a new prostate cancer theranostic radiopharmaceutical
2020 Meléndez-Alafort, L; Carpanese, D; Ferro-Flores, G; Ocampo-Garcia, B; Santos-Cuevas, C; Fracasso, G; De Nardo, L; Bolzati, C; Rosato, A
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen
2020 Carpanese, D.; Ferro-Flores, G.; Ocampo-Garcia, B.; Santos-Cuevas, C.; Salvarese, N.; Figini, M.; Fracasso, G.; De Nardo, L.; Bolzati, C.; Rosato, A.; Melendez-Alafort, L.
Development of a new prostate cancer theranostic radiopharmaceutical
2019 Melendez-Alafort1 Debora Carpanese, Laura; Ferro-Flores, Guillermina; Ocampo-García, Blanca; Leticia Santos-Cuevas, Clara; DE NARDO, Laura; Salvarese, Nicola; Fracaso, Giulio; Bolzati, Cristina; Rosato, Antonio
Dosimetry of 51MnCl2 and 52MnCl2 for PET application
2020 De Nardo, L.; Ferro-Flores, G.; Bolzati, C.; Esposito, J.; Meléndez-Alafort, L.